The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

John T. Reilly

Department of Haematology

Royal Hallamshire Hospital

Sheffield

UK

[email]@sheffield.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK. 2008 - 2012
  • Royal Hallamshire Hospital, Sheffield, UK. 2003 - 2007
  • Molecular Haematology Unit, Division of Molecular and Genetic Medicine, Royal Hallamshire Hospital, Sheffield, UK. 2002 - 2005
  • Academic Unit of Haematology, Henry Wellcome Laboratories for Medical Research, Sheffield, UK. 2005
  • UK NEQAS for Leucocyte Immunophenotyping, Department of Haematology, Royal Hallamshire Hospital, Glossop Road, UK. 2001

References

  1. Current treatment practices for essential thrombocythemia: survey results from European hematologists/oncologists. Reilly, J.T. Hematology (2012) [Pubmed]
  2. Anagrelide for the treatment of essential thrombocythemia: a survey among European hematologists/oncologists. Reilly, J.T. Hematology (2009) [Pubmed]
  3. Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs). Reilly, J.T. Leukemia (2008) [Pubmed]
  4. Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice. Reilly, J.T. Eur. J. Haematol. Suppl (2007) [Pubmed]
  5. Practical approach to treating essential thrombocythaemia: case studies. Reilly, J.T. Eur. J. Haematol. Suppl (2007) [Pubmed]
  6. Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?. Reilly, J.T. Br. J. Haematol. (2005) [Pubmed]
  7. Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasia. Reilly, J.T. Semin. Oncol. (2005) [Pubmed]
  8. FLT3 and its role in the pathogenesis of acute myeloid leukaemia. Reilly, J.T. Leuk. Lymphoma (2003) [Pubmed]
  9. Receptor tyrosine kinases in normal and malignant haematopoiesis. Reilly, J.T. Blood Rev. (2003) [Pubmed]
  10. Chronic neutrophilic leukaemia: a distinct clinical entity?. Reilly, J.T. Br. J. Haematol. (2002) [Pubmed]
  11. Class III receptor tyrosine kinases: role in leukaemogenesis. Reilly, J.T. Br. J. Haematol. (2002) [Pubmed]
  12. Cytogenetic and molecular genetic aspects of idiopathic myelofibrosis. Reilly, J.T. Acta Haematol. (2002) [Pubmed]
  13. UK NEQAS for leucocyte immunophenotyping: the first 10 years. Reilly, J.T., Barnett, D. J. Clin. Pathol. (2001) [Pubmed]
 
WikiGenes - Universities